Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening

MLA

Caisheng Wu, et al. “Identifying Potential Anti-COVID-19 Pharmacological Components of Traditional Chinese Medicine Lianhuaqingwen Capsule Based on Human Exposure and ACE2 Biochromatography Screening.” Acta Pharmaceutica Sinica B, Jan. 2021. EBSCOhost, https://doi.org/10.1016/j.apsb.2020.10.002.

APA

Caisheng Wu, Yun-Long Wu, Lei Lv, Lei Zhang, Yanqiu Gu, Yifeng Chai, Chun Chen, Mingshe Zhu, Jiayun Chen, Chunyan Zhu, Suping Wang, Yongfang Yuan, Guoqing Zhang, & Xiaofei Chen. (2021). Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2020.10.002

Chicago

Caisheng Wu, Yun-Long Wu, Lei Lv, Lei Zhang, Yanqiu Gu, Yifeng Chai, Chun Chen, et al. 2021. “Identifying Potential Anti-COVID-19 Pharmacological Components of Traditional Chinese Medicine Lianhuaqingwen Capsule Based on Human Exposure and ACE2 Biochromatography Screening.” Acta Pharmaceutica Sinica B, January. doi:10.1016/j.apsb.2020.10.002.